Literature DB >> 23512104

Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation.

Massimo Breccia, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23512104     DOI： 10.1007/s00277-013-1732-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes.

Authors:  Sotirios G Papageorgiou; Ioannis Kotsianidis; Anthi Bouchla; Argyris Symeonidis; Athanasios Galanopoulos; Nora-Athina Viniou; Eleftheria Hatzimichael; Theodoros P Vassilakopoulos; Dimitrios Gogos; Aikaterini Megalakaki; Panagiotis Zikos; Panagiotis Diamantopoulos; Alexandra Kourakli; Panagiota Giannoulia; Menelaos Papoutselis; Elias Poulakidas; Maria Arapaki; Anna Vardi; Achilles Anagnostopoulos; Despoina Mparmparousi; Maria Papaioannou; Eleni Bouronikou; Maria Dimou; Helen Papadaki; Panayiotis Panayiotidis; Vasiliki Pappa
Journal:  Ther Adv Hematol       Date:  2020-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.